Assuming that these are commonly loss-of-function mutations, these results are in line with the lower expression level of TKS5 in bladder cancer samples and could further support the tumour-suppressor function of this crucial protein. The gene discussed is SH3PXD2A; the disease is urinary bladder cancer.